Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Published Online
on August 26, 2004

Stroke. 2004
Published online before print August 26, 2004, doi: 10.1161/01.STR.0000141978.33388.eb
A more recent version of this article appeared on October 1, 2004
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
35/10/2282    most recent
01.STR.0000141978.33388.ebv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Iniesta, J. A.
Right arrow Articles by Corral, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Iniesta, J. A.
Right arrow Articles by Corral, J.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Genetics Home Reference
Related Collections
Right arrow Cerebral Aneurysm, AVM, & Subarachnoid hemorrhage
Right arrow Genetics of Stroke
Right arrow Platelets

Submitted on April 28, 2004
Revised on June 16, 2004
Accepted on July 7, 2004

The Platelet GP IIIa Polymorphism HPA-1 (PlA) Protects Against Subarachnoid Hemorrhage

Juan A. Iniesta PhD; Rocio González-Conejero PhD; Claudio Piqueras MD; Vicente Vicente PhD; and Javier Corral PhD*

From the Hematology and Oncology Service (R.G.-C., V.V., J.C.), Centro Regional de Hemodonación, Universidad de Murcia, Spain; the Neurology Section (J.A.I.), Hospital General Universitario, Murcia, Spain; and the Neurosurgery Service (C.P.), Hospital Virgen de la Arrixaca, Murcia, Spain.

* To whom correspondence should be addressed. E-mail: jcc{at}um.es.

Background and Purpose--Few genetic modifications have been identified to be associated with subarachnoid hemorrhage (SAH), most of them playing a role in the formation or size of aneurysms.

Methods--We evaluated the role of common and functional polymorphisms affecting the main platelet adhesive glycoproteins (GP) (GPIIIa: HPA-1; GPIa: HPA-5 and C807T; GPIb{alpha}: HPA-2 and VNTR) in the risk for development of the disease and in the severity of the onset. The study was performed in 103 patients with SAH, 103 matched controls, and 473 subjects from the general population.

Results--The HPA-1b (PlA2) allele significantly protected against SAH (OR, 0.48; 95% CI, 0.24 to 0.96; P=0.037). Interestingly, patients carrying this allele displayed larger aneurysms, but the extension of their hemorrhage and the clinical grade at presentation was significantly lower when compared with patients HPA-1 a/a (11.9±2.8 mm versus 8.8±2.2 mm, P=0.0001. Fisher grade ≤2: 68.4% versus 20%; P=0.0001; Hunt and Hess score <IV; 84.2% versus 53.8%; P=0.0187, respectively). The protection of the HPA-1b allele seemed to be exacerbated by the simultaneous presence of the HPA-2b allele. Thus, no patient carried this combination, which was present in 7.8% of controls (P=0.007).

Conclusions--We present the first evidence suggesting a protective role for the platelet GPIIIa HPA-1b allele in SAH. The suggested platelet hyper-reactivity determined by this allele could reduce the risk to suffer SAH, specially if the aneurysm is small, attenuate the severity of the hemorrhage, and reduce the clinical grade at presentation. This effect might be amplified by the simultaneous combination with the GPIb{alpha} HPA-2b allele.


Key words: aneurysm • genetics • hemostasis • subarachnoid hemorrhage




This article has been cited by other articles:


Home page
PediatricsHome page
D. C. Herak, M. R. Antolic, J. L. Krleza, M. Pavic, S. Dodig, V. Duranovic, A. B. Brkic, and R. Zadro
Inherited Prothrombotic Risk Factors in Children With Stroke, Transient Ischemic Attack, or Migraine
Pediatrics, April 1, 2009; 123(4): e653 - e660.
[Abstract] [Full Text] [PDF]


Home page
In VivoHome page
T. CHIRAS, E. D. PAPADAKIS, A. KATOPODI, E. CHATZIANESTI, K. FOURTOUNAS, S. PAPAKONSTANTINOU, I. THEODOROPOULOS, A. DAKOURAS, N. ZEREFOS, D. VALIS, et al.
Platelet GP IIIA Polymorphism HPA-1 (PLA1/2) Is Associated with Hypertension as the Primary Cause for End-stage Renal Disease in Hemodialysis Patients from Greece
In Vivo, January 1, 2009; 23(1): 177 - 181.
[Abstract] [Full Text] [PDF]


Home page
haematolHome page
L. Navarro-Nunez, M. L. Lozano, J. Rivera, J. Corral, V. Roldan, R. Gonzalez-Conejero, J. A. Iniesta, J. Montaner, V. Vicente, and C. Martinez
The association of the {beta}1-tubulin Q43P polymorphism with intracerebral hemorrhage in men
Haematologica, April 1, 2007; 92(4): 513 - 518.
[Abstract] [Full Text] [PDF]